HPV vaccination: the beginning of the end of cervical cancer? - A Review


Autoria(s): Lepique,Ana Paula; Rabachini,Tatiana; Villa,Luisa Lina
Data(s)

01/02/2009

Resumo

Human papillomavirus (HPV) is responsible for all cases of cervical cancer, as well as a great percentage of other anogenital tumors and oropharyngeal tumors. Since the main etiologic factor for these diseases is a virus, prophylactic measures are the best way to reduce the burden caused by the infection and associated disease. This review brings up to date information on the two commercially available prophylactic HPV vaccines against HPV, as well as presenting the ongoing research on HPV peptide, protein and dendritic cell based therapeutic vaccines.

Formato

text/html

Identificador

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000100001

Idioma(s)

en

Publicador

Instituto Oswaldo Cruz, Ministério da Saúde

Fonte

Memórias do Instituto Oswaldo Cruz v.104 n.1 2009

Palavras-Chave #human papillomavirus #anogenital cancers #prophylactic vaccine #therapeutic vaccine #clinical trial
Tipo

journal article